Results 31 to 40 of about 376 (102)

Bark and ambrosia beetles on native and transplanted dead wood along an altitudinal tropical forest gradient

Biotropica, Volume 56, Issue 3, May 2024.
Bark and ambrosia beetles were reared from Ficus wood baits along altitudinal tropical forest gradient. Some baits were transplanted below their trees' range of distribution to simulate the effects of climate change. While there was a distinct turnover in community composition along the gradient, beetles were readily colonizing the transplants, thereby
Matthias Weiss, Kateřina Zimová, Martin Mogia, Vojtech Novotny   +3 more
wiley   +1 more source

Conceptual review of symbolic cultural practices in children's racial/ethnic identity: Making room for mixed methods inquiry

Family Relations, Volume 73, Issue 1, Page 561-577, February 2024.
Abstract Objective Children are shaped by familial, cultural, societal, and environmental factors that impact development across multiple domains, contexts, and ecological systems. This conceptual review examines studies that address how symbolic cultural practices shape racial/ethnic identity development in early childhood (ages 3–6).
Amber B. Sansbury, Megan G. Stutesman, Divya Varier   +2 more
wiley   +1 more source

Antimicrobial adhesive films by plasma-enabled polymerisation of m-cresol. [PDF]

Sci Rep, 2022
Hartl H, Li W, Michl TD, Anangi R, Speight R, Vasilev K, Ostrikov KK, MacLeod J.   +7 more
europepmc   +1 more source

Autumnal migration patterns of hoverflies (Diptera: Syrphidae): interannual variability in timing and sex ratio. [PDF]

PeerJ, 2022
Hlaváček A, Lučan RK, Hadrava J.
europepmc   +1 more source

Individuality and stability of the koala (Phascolarctos cinereus) faecal microbiota through time. [PDF]

PeerJ, 2023
Eisenhofer R, Brice KL, Blyton MD, Bevins SE, Leigh K, Singh BK, Helgen KM, Hough I, Daniels CB, Speight N, Moore BD.   +10 more
europepmc   +1 more source

Neutralising antibody potency against SARS-CoV-2 wild-type and omicron BA.1 and BA.4/5 variants in patients with inflammatory bowel disease treated with infliximab and vedolizumab after three doses of COVID-19 vaccine (CLARITY IBD): an analysis of a prospective multicentre cohort study. [PDF]

Lancet Gastroenterol Hepatol, 2023
Liu Z, Le K, Zhou X, Alexander JL, Lin S, Bewshea C, Chanchlani N, Nice R, McDonald TJ, Lamb CA, Sebastian S, Kok K, Lees CW, Hart AL, Pollok RC, Boyton RJ, Altmann DM, Pollock KM, Goodhand JR, Kennedy NA, Ahmad T, Powell N, CLARITY study investigators.   +22 more
europepmc   +1 more source

UK consensus recommendations for clinical management of cancer risk for women with germline pathogenic variants in cancer predisposition genes: RAD51C, RAD51D, BRIP1 and PALB2. [PDF]

J Med Genet, 2023
Hanson H, Kulkarni A, Loong L, Kavanaugh G, Torr B, Allen S, Ahmed M, Antoniou AC, Cleaver R, Dabir T, Evans DG, Golightly E, Jewell R, Kohut K, Manchanda R, Murray A, Murray J, Ong KR, Rosenthal AN, Woodward ER, Eccles DM, Turnbull C, Turnbull C, Tischkowitz M, Consensus meeting attendees, Lalloo F.   +25 more
europepmc   +1 more source

Quantifying prediction of pathogenicity for within-codon concordance (PM5) using 7541 functional classifications of BRCA1 and MSH2 missense variants. [PDF]

Genet Med, 2022
Loong L, Cubuk C, Choi S, Allen S, Torr B, Garrett A, Loveday C, Durkie M, Callaway A, Burghel GJ, Drummond J, Robinson R, Berry IR, Wallace A, Eccles DM, Tischkowitz M, Ellard S, Ware JS, Hanson H, Turnbull C, CanVIG-UK.   +20 more
europepmc   +1 more source

Antibody decay, T cell immunity and breakthrough infections following two SARS-CoV-2 vaccine doses in inflammatory bowel disease patients treated with infliximab and vedolizumab. [PDF]

Nat Commun, 2022
Lin S, Kennedy NA, Saifuddin A, Sandoval DM, Reynolds CJ, Seoane RC, Kottoor SH, Pieper FP, Lin KM, Butler DK, Chanchlani N, Nice R, Chee D, Bewshea C, Janjua M, McDonald TJ, Sebastian S, Alexander JL, Constable L, Lee JC, Murray CD, Hart AL, Irving PM, Jones GR, Kok KB, Lamb CA, Lees CW, Altmann DM, Boyton RJ, Goodhand JR, Powell N, Ahmad T, CLARITY IBD study.   +32 more
europepmc   +1 more source

Self-expanding Transcatheter vs Surgical Aortic Valve Replacement in Intermediate-Risk Patients: 5-Year Outcomes of the SURTAVI Randomized Clinical Trial. [PDF]

JAMA Cardiol, 2022
Van Mieghem NM, Deeb GM, Søndergaard L, Grube E, Windecker S, Gada H, Mumtaz M, Olsen PS, Heiser JC, Merhi W, Kleiman NS, Chetcuti SJ, Gleason TG, Lee JS, Cheng W, Makkar RR, Crestanello J, George B, George I, Kodali S, Yakubov SJ, Serruys PW, Lange R, Piazza N, Williams MR, Oh JK, Adams DH, Li S, Reardon MJ, SURTAVI Trial Investigators.   +29 more
europepmc   +1 more source